Neoadjuvant hormone therapy
refers to hormone therapy that is given before a primary
prostate cancer treatment. The hormone therapy is being
used to shrink the size of the prostate gland and thereby
make the primary treatment more effective. A large prostate
gland may cause complications during the prostatectomy
or cause the surrounding organs to be damaged during
external beam radiation therapy. An enlarged gland could
also cause the prostate to be ineffectively treated
during cryotherapy or brachytherapy for prostate cancer.
|
